October 7, 2021
Women Are Leading the Way in Life Sciences
Utah’s life sciences industry is filled with extraordinary female leaders and innovators. Biosphere, the magazine of Utah’s life science industry, interviewed some of the most prominent women leaders in the region’s biotech hub, including IDbyDNA’s Vice President of Operations and Corporate Affairs, Ivy Estabrooke, PhD.
Related News
April 26, 2022
IDbyDNA Improves Analytical Performance and User Experience of Its Explify Platform and Respiratory and Urinary Pathogen ID/AMR Panels
With IDbyDNA’s latest software update to the Explify® Platform, labs can now take their NGS analysis of respiratory and urinary samples to the next level with improved sample management, strengthened user management controls, an enhanced total AMR picture and detection of the latest SARS-CoV-2 variants.
+ read more about IDbyDNA Improves Analytical Performance and User Experience of Its Explify Platform and Respiratory and Urinary Pathogen ID/AMR PanelsApril 7, 2022
IDbyDNA Receives Second-Year Funding to Continue Participation in DARPA-funded DIGET Program
Awarded continued funding by MRIGlobal, IDbyDNA will continue to support DARPA’s “Detect it With Gene Editing Technologies” (DIGET) program focused on developing a next-generation, battlefield-tested device that delivers improved diagnostic testing of infectious disease threats.
+ read more about IDbyDNA Receives Second-Year Funding to Continue Participation in DARPA-funded DIGET ProgramApril 4, 2022
MedCity News: The Diagnostic Dilemma of Co-Infections Requires Novel Solutions
Co-infections are common in patients with COVID-19 and are associated with a 3.3-fold higher risk of death. In a MedCity News article, Amy Hanson, PharmD, outlines how Precision Metagenomics offers better diagnostic testing to identify pathogens otherwise evading detection.
+ read more about MedCity News: The Diagnostic Dilemma of Co-Infections Requires Novel SolutionsMarch 28, 2022
The Tech Tribune Awards IDbyDNA As One of the 2022 Best Tech Startups in Salt Lake City
Based on revenue potential, leadership team, product traction and competitive landscape, The Tech Tribune’s editorial team identified IDbyDNA as one of the very best tech startups across renowned tech hubs in the United States.
+ read more about The Tech Tribune Awards IDbyDNA As One of the 2022 Best Tech Startups in Salt Lake CityFebruary 24, 2022
Utah Business Names Steven Flygare to the 40 Under 40 Professionals for 2022
Each year Utah Business celebrates 40 business professionals under the age of 40 who are working to evolve the state of Utah’s business landscape.
+ read more about Utah Business Names Steven Flygare to the 40 Under 40 Professionals for 2022February 16, 2022
Utah Life Science Day Draws State Legislators and Industry Representatives to Capitol Hill
IDbyDNA showcased its contributions to the Utah life science industry, introducing its innovations to an audience of State legislators and industry leaders.
+ read more about Utah Life Science Day Draws State Legislators and Industry Representatives to Capitol HillFebruary 10, 2022
IDbyDNA is Making it Easier to Accurately Identify Pathogens that Cause Infectious Diseases
Utah Business recognizes IDbyDNA as a technology leader in infectious disease testing. Outlined in a feature article, they discuss how IDbyDNA’s Precision Metagenomics platform gives hope to identify and treat infectious diseases more accurately and precisely.
+ read more about IDbyDNA is Making it Easier to Accurately Identify Pathogens that Cause Infectious DiseasesJanuary 24, 2022
IDbyDNA Appoints Susan (Siw) Daniels as Vice President of R&D and Member of Executive Committee
Daniels fills a key leadership role at a critical time to drive the company’s R&D initiatives, team development and product portfolio expansion, taking IDbyDNA into the future of precision metagenomics with cutting edge breakthroughs in infectious disease testing.
+ read more about IDbyDNA Appoints Susan (Siw) Daniels as Vice President of R&D and Member of Executive CommitteeOctober 13, 2021
IDbyDNA Expands Scientific Advisory Board with Infectious Disease, Sequencing & FDA Leaders
On the heels of its appointment of Next-Generation Sequencing (NGS) leader Neil Gunn as CEO, IDbyDNA announces the addition of several notable leaders to their Scientific Advisory Board, including Dr. Adrian Egli, Dr. Tamara V. Feldblyum, Dr. Karl Voelkerding, Dr. Christopher Woods, and Dr. Stephen Young.
+ read more about IDbyDNA Expands Scientific Advisory Board with Infectious Disease, Sequencing & FDA LeadersSeptember 17, 2021
Taking the Guesswork Out of Diagnostics
+ read more about Taking the Guesswork Out of Diagnostics
August 4, 2021
Next-Generation Sequencing and the Diagnosis of Disease
+ read more about Next-Generation Sequencing and the Diagnosis of Disease
August 2, 2021
IDbyDNA Welcomes Biotech Top Talents Wendy Chang and Reza Anayat to Its Company Leadership Team
In support of their mission to become the Precision Metagenomics company in infectious disease testing and management, IDbyDNA has filled…
+ read more about IDbyDNA Welcomes Biotech Top Talents Wendy Chang and Reza Anayat to Its Company Leadership TeamJuly 15, 2021
DARPA to Develop Hand-Held Disease Detection Device
+ read more about DARPA to Develop Hand-Held Disease Detection Device
May 5, 2021
IDbyDNA Appoints Next-Gen Sequencing Executive Neil Gunn as New CEO
Infectious disease continues to be a leading cause of illness, morbidity and mortality around the world. In the fight to better understand all pathogens, including the SARS-CoV-2 lineage and its mutations, IDbyDNA, the pioneer in Precision Metagenomics, is focused on broadening availability for its Next-Generation Sequencing (NGS) targeted products. With that, the company has appointed NGS leader Neil Gunn as its new CEO to drive the next phase of growth.
+ read more about IDbyDNA Appoints Next-Gen Sequencing Executive Neil Gunn as New CEOApril 6, 2021
IDbyDNA’s Metagenomics Suite Future-Proofs Labs for Coming Pathogen Crises
+ read more about IDbyDNA’s Metagenomics Suite Future-Proofs Labs for Coming Pathogen Crises
March 23, 2021
IDbyDNA Boosts Its Global Metagenomic Respiratory Pathogen/AMR Surveillance Solution to Now Offer Enhanced SARS-CoV-2 Variant Interpretation
+ read more about IDbyDNA Boosts Its Global Metagenomic Respiratory Pathogen/AMR Surveillance Solution to Now Offer Enhanced SARS-CoV-2 Variant Interpretation
February 27, 2021
How Variant Surveillance Could Drive a Sequencing Boom
+ read more about How Variant Surveillance Could Drive a Sequencing Boom
February 9, 2021
CareDx CEO: ‘We’re Not Just a One-Trick Pony’
+ read more about CareDx CEO: ‘We’re Not Just a One-Trick Pony’
January 29, 2021
CareDx Adds Infectious Disease Focus to Transplant Diagnostics with IDbyDNA
+ read more about CareDx Adds Infectious Disease Focus to Transplant Diagnostics with IDbyDNA
January 26, 2021
Under 30 Alum Mammoth Biosciences To Develop Diagnostics For Department Of Defense
+ read more about Under 30 Alum Mammoth Biosciences To Develop Diagnostics For Department Of Defense
January 19, 2021
Mammoth, IDbyDNA Get DARPA Funds for CRISPR Diagnostics Development
+ read more about Mammoth, IDbyDNA Get DARPA Funds for CRISPR Diagnostics Development
January 18, 2021
DARPA to Fund CRISPR Diagnostics Using Mammoth, IDbyDNA Technologies
+ read more about DARPA to Fund CRISPR Diagnostics Using Mammoth, IDbyDNA TechnologiesJanuary 18, 2021
Genetic Engineering and Biotechnology News
+ read more about Genetic Engineering and Biotechnology News
January 15, 2021
The Future Is Now: How Metagenomics Could Affect Infectious Disease Diagnostics
+ read more about The Future Is Now: How Metagenomics Could Affect Infectious Disease Diagnostics
January 14, 2021
The fight against Sars-CoV-2 in 2021: What’s next?
+ read more about The fight against Sars-CoV-2 in 2021: What’s next?
January 14, 2021
DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech
+ read more about DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance TechJanuary 14, 2021
IDbyDNA Announces Engagement in United States Defense Advanced Research Projects Agency (DARPA) Program to Detect Threats Using Gene Editing Technologies
+ read more about IDbyDNA Announces Engagement in United States Defense Advanced Research Projects Agency (DARPA) Program to Detect Threats Using Gene Editing Technologies
January 7, 2021
CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients
+ read more about CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients
January 7, 2021
CareDx Announces AlloID and Exclusive Partnership with IDbyDNA
+ read more about CareDx Announces AlloID and Exclusive Partnership with IDbyDNA
December 1, 2020
IDbyDNA Receives Accreditation from College of American Pathologists (CAP)
+ read more about IDbyDNA Receives Accreditation from College of American Pathologists (CAP)
November 20, 2020
Illumina, IDbyDNA Flesh Out Sequencing-Based Respiratory Tests
+ read more about Illumina, IDbyDNA Flesh Out Sequencing-Based Respiratory Tests
November 19, 2020
Startups Apply Powerful Genetic Sequencing Technique to Covid-19 Battle
+ read more about Startups Apply Powerful Genetic Sequencing Technique to Covid-19 Battle
October 15, 2020
Illumina and IDbyDNA Launch Test That May Find Next Epidemic
+ read more about Illumina and IDbyDNA Launch Test That May Find Next Epidemic
October 15, 2020
IDbyDNA and Illumina Launch New Rapid Test to Better Detect Respiratory Co-Infections and Identify Antibiotic-Resistant Pathogens
+ read more about IDbyDNA and Illumina Launch New Rapid Test to Better Detect Respiratory Co-Infections and Identify Antibiotic-Resistant Pathogens
September 28, 2020
Healthcare Execs Discuss Working During a Pandemic
+ read more about Healthcare Execs Discuss Working During a Pandemic
September 1, 2020
IDbyDNA Commercializing Explify Platform for Comprehensive Pathogen Detection and Surveillance
+ read more about IDbyDNA Commercializing Explify Platform for Comprehensive Pathogen Detection and Surveillance
July 23, 2020
AWS and 1 Strategy Case Study: IDbyDNA and Application Migration, HIPAA Compliance, and DevOps Workflows
+ read more about AWS and 1 Strategy Case Study: IDbyDNA and Application Migration, HIPAA Compliance, and DevOps Workflows
June 19, 2020
GenomeWeb Covers News of IDbyDNA’s Announcement this Week of SARS-CoV-2 Detection with the Gatot Soebroto Army Hospital in Indonesia
+ read more about GenomeWeb Covers News of IDbyDNA’s Announcement this Week of SARS-CoV-2 Detection with the Gatot Soebroto Army Hospital in Indonesia
June 18, 2020
Metagenomics As a Tool To Diagnose and Understand COVID-19
IDbyDNA Chief Medical Officer Dr. Robert Schlaberg was just featured in an interview by Technology Networks, where he discusses how next-generation sequencing and metagenomics-based testing with the Explify Platform can address respiratory infections like SARS-CoV-2.
+ read more about Metagenomics As a Tool To Diagnose and Understand COVID-19June 16, 2020
IDbyDNA to Help Indonesian Government Fight COVID-19 Pandemic
Metagenomics Innovator Delivers First NGS-Based SARS-CoV-2 Detection for Gatot Soebroto Army Hospital.
+ read more about IDbyDNA to Help Indonesian Government Fight COVID-19 PandemicMarch 17, 2020
IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions
IDbyDNA announces a global strategic partnership with Illumina to bring next-generation sequencing based workflows to the global microbiology market.
+ read more about IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease SolutionsJanuary 29, 2020
IDbyDNA Raises $20 Million in Series B Financing to Continue Advancements in Infectious Disease Diagnosis and Pathogen Identification
IDbyDNA, Inc., a metagenomics technology company setting the standard for detection, identification, and interpretation of microorganisms and their role in human health, today announced the raise of $20 million in its Series B financing led by ARTIS Ventures and joined by Genesys Capital and others.
+ read more about IDbyDNA Raises $20 Million in Series B Financing to Continue Advancements in Infectious Disease Diagnosis and Pathogen IdentificationJanuary 28, 2020
Novel Wuhan Coronavirus Detectable with IDbyDNA Explify Respiratory Test
IDbyDNA, Inc., a metagenomics technology company setting the standard for detection, identification and interpretation of microorganisms and their role in human health, today announced that its currently available Explify Respiratory test can detect 2019-nCoV in addition to over 900 other viral, bacterial, fungal and parasitic pathogens.
+ read more about Novel Wuhan Coronavirus Detectable with IDbyDNA Explify Respiratory Test